vTv Therapeutics Secures $51M Through Private Placement and Warrants

vTv Therapeutics (VTVT) has shared an announcement.

vTv Therapeutics Inc. has successfully completed a private placement of securities, raising approximately $51 million by selling Class A common shares and pre-funded warrants to institutional accredited investors. The transaction included the sale of over 464,000 shares at $11.81 each and warrants for nearly 3.85 million shares at $11.80 per warrant. These financial instruments came with rights for investors, including the ability to nominate board directors under certain conditions, participation rights in future financings, and the right to purchase additional stock. Alongside this, the company has made amendments to existing agreements and entered into a registration rights agreement to facilitate the resale of these securities, ensuring the investors’ ability to potentially profit from their investment.

See more data about VTVT stock on TipRanks’ Stock Analysis page.